Evidence map›Paper›PMID 31372242›Full record

ArticleCell death discovery

Correction: Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma.

Dorota L Stankowska, Mi-Hyun Nam, Rooban B Nahomi, Renuka M Chaphalkar, Sandip K Nandi, Rafal Fudala, Raghu R Krishnamoorthy, Ram H Nagaraj

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death discovery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Dorota L Stankowska *1Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, UNT Health Science Center, Fort Worth, TX 76107 USA.
Mi-Hyun Nam *2Sue Anschutz-Rodgers Eye Center and Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO 80045 USA.
Rooban B Nahomi2Sue Anschutz-Rodgers Eye Center and Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO 80045 USA.
Renuka M Chaphalkar1Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, UNT Health Science Center, Fort Worth, TX 76107 USA.
Sandip K Nandi2Sue Anschutz-Rodgers Eye Center and Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO 80045 USA.
Rafal Fudala3Department of Microbiology, Immunology and Genetics, UNT Health Science Center, Fort Worth, TX 76107 USA.
Raghu R Krishnamoorthy1Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, UNT Health Science Center, Fort Worth, TX 76107 USA.
Ram H Nagaraj2Sue Anschutz-Rodgers Eye Center and Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO 80045 USA.

Funding

Mechanisms underlying endothelin mediated neurodegeneration in glaucomaR01EY028179 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI KRISHNAMOORTHY, RAGHU R · 2017 to 2025
$2.9M
NEI NIH HHS R01 EY028179
6 · The paper itself

Abstract

[This corrects the article DOI: 10.1038/s41420-019-0194-2.].

Identifiers

PMID31372242
PMCPMC6668458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.